Geode Capital Management LLC Takes $2.58 Million Position in Ardent Health Partners, LLC (NYSE:ARDT)

Geode Capital Management LLC bought a new position in shares of Ardent Health Partners, LLC (NYSE:ARDTFree Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 140,436 shares of the company’s stock, valued at approximately $2,581,000. Geode Capital Management LLC owned approximately 0.10% of Ardent Health Partners at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Barclays PLC acquired a new stake in Ardent Health Partners during the third quarter valued at approximately $385,000. Pier Capital LLC acquired a new stake in shares of Ardent Health Partners during the 3rd quarter valued at $4,040,000. Jane Street Group LLC bought a new stake in shares of Ardent Health Partners during the 3rd quarter worth $567,000. Wellington Management Group LLP acquired a new position in shares of Ardent Health Partners in the 3rd quarter worth $28,724,000. Finally, Soros Fund Management LLC acquired a new stake in shares of Ardent Health Partners during the third quarter worth $4,595,000.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on ARDT shares. Stephens reiterated an “overweight” rating and issued a $24.00 price target on shares of Ardent Health Partners in a research report on Thursday, September 19th. Royal Bank of Canada reiterated an “outperform” rating and issued a $23.00 target price on shares of Ardent Health Partners in a report on Thursday, November 14th. Bank of America lowered shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their price target for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. Truist Financial decreased their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Monday. Finally, Leerink Partners boosted their target price on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Ardent Health Partners presently has an average rating of “Buy” and an average price target of $22.00.

View Our Latest Research Report on ARDT

Ardent Health Partners Stock Up 2.7 %

ARDT opened at $16.35 on Wednesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners, LLC has a fifty-two week low of $14.57 and a fifty-two week high of $20.72. The business’s 50-day moving average price is $16.66.

Ardent Health Partners Profile

(Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

See Also

Want to see what other hedge funds are holding ARDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ardent Health Partners, LLC (NYSE:ARDTFree Report).

Institutional Ownership by Quarter for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.